Table 2.
Univariate and multivariate Cox regression analyses of clinicopathological characteristics along with SNHG17 expression in PC patients.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | ||
| T stage | 492 | ||||
| T2 | 189 | Reference | |||
| T3&T4 | 303 | 3.294 (0.612-17.727) | 0.165 | ||
| N stage | 426 | ||||
| N0 | 347 | Reference | |||
| N1 | 79 | 3.516 (0.778-15.896) | 0.102 | ||
| M stage | 458 | ||||
| M0 | 455 | Reference | |||
| M1 | 3 | 59.383 (6.520-540.817) | <0.001 | 16.693 (1.705-163.463) | 0.016 |
| PSA (ng/ml) | 442 | ||||
| <4 | 415 | Reference | |||
| ≥4 | 27 | 10.479 (2.471-44.437) | 0.001 | 4.325 (0.955-19.585) | 0.057 |
| Gleason score | 499 | ||||
| 6&7 | 293 | Reference | |||
| 8&9&10 | 206 | 6.664 (1.373-32.340) | 0.019 | 8.387 (0.831-84.642) | 0.071 |
| SNHG17 | 499 | ||||
| Low | 249 | Reference | |||
| High | 250 | 8.428 (1.064-66.730) | 0.043 | 13.520 (1.053-173.563) | 0.046 |